TY - JOUR AU - Harbeck, N. AU - Thomssen, C. PY - 2011 DA - 2011// TI - A new look at node-negative breast cancer JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2011-S1-51 DO - 10.1634/theoncologist.2011-S1-51 ID - Harbeck2011 ER - TY - STD TI - Cancer du sein: Epidémiologie, Prise en charge, résultats thérapeutiques rt cout. registre de l’institut Salah Azaiez. 2005:18. ID - ref2 ER - TY - JOUR AU - Habel, L. A. AU - Shak, S. AU - Jacobs, M. K. AU - Capra, A. AU - Alexander, C. AU - Pho, M. PY - 2006 DA - 2006// TI - A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients JO - Breast Cancer Res VL - 8 UR - https://doi.org/10.1186/bcr1412 DO - 10.1186/bcr1412 ID - Habel2006 ER - TY - JOUR AU - Maalej, M. AU - Hentati, D. AU - Messai, T. AU - Kochbati, L. AU - El May, A. AU - Mrad, K. PY - 2008 DA - 2008// TI - Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study JO - Bull Cancer VL - 95 ID - Maalej2008 ER - TY - JOUR PY - 1999 DA - 1999// TI - Systemic treatment for early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women JO - Lancet VL - 339 ID - ref5 ER - TY - JOUR AU - Iwamoto, E. AU - Fukutomi, T. AU - Akashi-Tanaka, S. PY - 2001 DA - 2001// TI - Validation and problems of St-Gallen recommendations of adjuvant therapy for node-negative invasive breast cancer in Japanese patients JO - Jpn J Clin Oncol VL - 31 UR - https://doi.org/10.1093/jjco/hye056 DO - 10.1093/jjco/hye056 ID - Iwamoto2001 ER - TY - JOUR AU - Bull, S. B. AU - Ozcelik, H. AU - Pinnaduwage, D. AU - Blackstein, M. E. AU - Sutherland, D. A. AU - Pritchard, K. I. PY - 2004 DA - 2004// TI - The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.09.128 DO - 10.1200/JCO.2004.09.128 ID - Bull2004 ER - TY - JOUR AU - Blancas, I. AU - Garcia-Puche, J. AU - Bermejo, B. AU - Hanrahan, E. AU - Monteagudo, C. AU - Martinez-Agullo, A. PY - 2006 DA - 2006// TI - Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl169 DO - 10.1093/annonc/mdl169 ID - Blancas2006 ER - TY - JOUR AU - Martín, M. AU - Seguí, M. A. AU - Antón, A. AU - Ruiz, A. AU - Ramos, M. AU - Adrover, E. PY - 2010 DA - 2010// TI - Adjuvant docetaxel for high-risk, node-negative breast cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0910320 DO - 10.1056/NEJMoa0910320 ID - Martín2010 ER - TY - JOUR AU - Regan, M. M. AU - Neven, P. AU - Giobbie-Hurder, A. AU - Goldhirsch, A. AU - Ejlertsen, B. AU - Mauriac, L. PY - 2011 DA - 2011// TI - Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70270-4 DO - 10.1016/S1470-2045(11)70270-4 ID - Regan2011 ER - TY - BOOK AU - Slamon, D. E. W. AU - Robert, N. PY - 2009 DA - 2009// TI - Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel with trastuzumab with docetaxel, carboplatin and trastuzumab in HER2/neu positive early breast cancer patients:BCIRG006 study [abstracts 62] PB - San Antonio Breast Cancer symposium CY - San Antonio,TX ID - Slamon2009 ER - TY - JOUR AU - Goldhirsch, A. AU - Glick, J. H. AU - Gelber, R. D. AU - Senn, H. J. PY - 1998 DA - 1998// TI - Meeting highlights: international consensus panel on the treatment of primary breast cancer JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.21.1601 DO - 10.1093/jnci/90.21.1601 ID - Goldhirsch1998 ER - TY - JOUR AU - Kuru, B. AU - Camlibel, M. AU - Ali Gulcelik, M. AU - Alagol, H. PY - 2003 DA - 2003// TI - Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas JO - J Surg Oncol VL - 83 UR - https://doi.org/10.1002/jso.10264 DO - 10.1002/jso.10264 ID - Kuru2003 ER - TY - JOUR AU - Wang, B. AU - Wang, N. AU - Xue, C. AU - Jiang, B. AU - Wang, Y. PY - 2008 DA - 2008// TI - Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer JO - Chin-Ger J Clin Oncol VL - 7 UR - https://doi.org/10.1007/s10330-008-0030-2 DO - 10.1007/s10330-008-0030-2 ID - Wang2008 ER - TY - JOUR AU - Trudeau, M. E. AU - Pritchard, K. I. AU - Chapman, J. A. AU - Hanna, W. M. AU - Kahn, H. J. AU - Murray, D. PY - 2005 DA - 2005// TI - Prognostic factors affecting the natural history of node-negative breast cancer JO - Breast Cancer Res Treat VL - 89 UR - https://doi.org/10.1007/s10549-004-1368-y DO - 10.1007/s10549-004-1368-y ID - Trudeau2005 ER - TY - JOUR AU - Volpi, A. AU - De Paola, F. AU - Nanni, O. AU - Granato, A. M. AU - Bajorko, P. AU - Becciolini, A. PY - 2000 DA - 2000// TI - Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study JO - Breast Cancer Res Treat VL - 63 UR - https://doi.org/10.1023/A:1006464426977 DO - 10.1023/A:1006464426977 ID - Volpi2000 ER - TY - JOUR AU - Mirza, A. N. AU - Mirza, N. Q. AU - Vlastos, G. AU - Singletary, S. E. PY - 2002 DA - 2002// TI - Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years JO - Ann Surg VL - 235 UR - https://doi.org/10.1097/00000658-200201000-00003 DO - 10.1097/00000658-200201000-00003 ID - Mirza2002 ER - TY - JOUR AU - Jagsi, R. AU - Raad, R. A. AU - Goldberg, S. AU - Sullivan, T. AU - Michaelson, J. AU - Powell, S. N. PY - 2005 DA - 2005// TI - Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation JO - Int J Radiat Oncol VL - 62 UR - https://doi.org/10.1016/j.ijrobp.2004.12.014 DO - 10.1016/j.ijrobp.2004.12.014 ID - Jagsi2005 ER - TY - JOUR AU - Kato, T. AU - Kameoka, S. AU - Kimura, T. AU - Nishikawa, T. AU - Kasajima, T. PY - 2001 DA - 2001// TI - Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer JO - Breast Cancer Res Treat VL - 65 UR - https://doi.org/10.1023/A:1010668616265 DO - 10.1023/A:1010668616265 ID - Kato2001 ER - TY - JOUR AU - Chevallier, B. AU - Mosseri, V. AU - Dauce, J. P. AU - Bastit, P. AU - Julien, J. P. AU - Asselain, B. PY - 1990 DA - 1990// TI - A prognostic score in histological node negative breast cancer JO - Br J Cancer VL - 61 UR - https://doi.org/10.1038/bjc.1990.96 DO - 10.1038/bjc.1990.96 ID - Chevallier1990 ER - TY - JOUR AU - Goldhirsch, A. AU - Ingle, J. N. AU - Gelber, R. D. AU - Coates, A. S. AU - Thurlimann, B. AU - Senn, H. J. PY - 2009 DA - 2009// TI - Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp322 DO - 10.1093/annonc/mdp322 ID - Goldhirsch2009 ER - TY - JOUR AU - Klintman, M. AU - Bendahl, P. -. O. AU - Grabau, D. AU - Lövgren, K. AU - Malmström, P. AU - Fernö, M. PY - 2009 DA - 2009// TI - The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer JO - Mod Pathol VL - 23 UR - https://doi.org/10.1038/modpathol.2009.167 DO - 10.1038/modpathol.2009.167 ID - Klintman2009 ER - TY - JOUR AU - Tai, P. AU - Yu, E. AU - Sadikov, E. AU - Joseph, K. A. PY - 2009 DA - 2009// TI - Long-term study of radiation therapy in T1-2 node-negative breast cancer patients in relation to the number of axillary nodes examined JO - Int J Radiat Oncol VL - 74 UR - https://doi.org/10.1016/j.ijrobp.2008.08.035 DO - 10.1016/j.ijrobp.2008.08.035 ID - Tai2009 ER - TY - JOUR AU - Moorman, P. G. AU - Hamza, A. AU - Marks, J. R. AU - Olson, J. A. PY - 2001 DA - 2001// TI - Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma JO - Cancer VL - 91 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Moorman2001 ER - TY - JOUR AU - Karlsson, P. AU - Cole, B. F. AU - Price, K. N. AU - Coates, A. S. AU - Castiglione-Gertsch, M. AU - Gusterson, B. A. PY - 2007 DA - 2007// TI - The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.8152 DO - 10.1200/JCO.2006.09.8152 ID - Karlsson2007 ER - TY - JOUR AU - Mersin, H. AU - Yıldırım, E. AU - Bulut, H. AU - Berberoğlu, U. PY - 2003 DA - 2003// TI - The prognostic significance of total lymph node number in patients with axillary lymph node-negative breast cancer JO - Eur J Surg Oncol EJSO VL - 29 UR - https://doi.org/10.1053/ejso.2002.1285 DO - 10.1053/ejso.2002.1285 ID - Mersin2003 ER - TY - JOUR AU - Lee, A. H. S. AU - Pinder, S. E. AU - Macmillan, R. D. AU - Mitchell, M. AU - Ellis, I. O. AU - Elston, C. W. PY - 2006 DA - 2006// TI - Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2005.10.021 DO - 10.1016/j.ejca.2005.10.021 ID - Lee2006 ER - TY - JOUR AU - De Mascarel, I. AU - Bonichon, F. AU - Durand, M. AU - Mauriac, L. AU - MacGrogan, G. AU - Soubeyran, I. PY - 1998 DA - 1998// TI - Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers JO - Eur J Cancer VL - 34 UR - https://doi.org/10.1016/S0959-8049(97)00344-4 DO - 10.1016/S0959-8049(97)00344-4 ID - De Mascarel1998 ER - TY - JOUR AU - Goldhirsch, A. AU - Wood, W. C. AU - Gelber, R. D. AU - Coates, A. S. AU - Thurlimann, B. AU - Senn, H. J. PY - 2007 DA - 2007// TI - Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 JO - Ann Oncol VL - 18 UR - https://doi.org/10.1093/annonc/mdm271 DO - 10.1093/annonc/mdm271 ID - Goldhirsch2007 ER - TY - JOUR AU - Reed, W. AU - Hannisdal, E. AU - Boehler, P. J. AU - Gundersen, S. AU - Host, H. AU - Nesland, J. M. PY - 2000 DA - 2000// TI - The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-Y DO - 3.0.CO;2-Y ID - Reed2000 ER - TY - JOUR AU - Engel, R. H. AU - Kaklamani, V. G. PY - 2007 DA - 2007// TI - HER2-positive breast cancer JO - Drugs VL - 67 UR - https://doi.org/10.2165/00003495-200767090-00006 DO - 10.2165/00003495-200767090-00006 ID - Engel2007 ER - TY - JOUR AU - Chia, S. AU - Norris, B. AU - Speers, C. AU - Cheang, M. AU - Gilks, B. AU - Gown, A. M. PY - 2008 DA - 2008// TI - Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.8659 DO - 10.1200/JCO.2007.15.8659 ID - Chia2008 ER - TY - JOUR AU - Tovey, S. M. AU - Brown, S. AU - Doughty, J. C. AU - Mallon, E. A. AU - Cooke, T. G. AU - Grant, S. PY - 2009 DA - 2009// TI - Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604940 DO - 10.1038/sj.bjc.6604940 ID - Tovey2009 ER -